As of May 27
| +0.94 / +0.95%|
The 8 analysts offering 12-month price forecasts for Abiomed Inc have a median target of 118.50, with a high estimate of 145.00 and a low estimate of 99.26. The median estimate represents a +18.81% increase from the last price of 99.74.
The current consensus among 9 polled investment analysts is to Buy stock in Abiomed Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.